Company Overview and News

 
BHP Billiton Braves Iron-Ore Price Slump on Robust Yield

15h zacks
On May 22, we issued an updated research report on premium basic materials company — BHP Billiton Limited (BHP - Free Report) . The stock currently carries a Zacks Rank #3 (Hold), but flaunts a VGM Score of A. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Let's dig a little deeper into the fundamental factors of the stock. Gaining on Higher Productivity & Liquidity Over the past five years, BHP Billiton has gathered productivity gains worth $12 billion.

 
Colombia coal output falls 11.7 pct in Q1 to 19.6 mln tonnes

16h reuters
BOGOTA, May 23 (Reuters) - Colombia, the world’s fifth-largest exporter of coal, produced 19.6 million tonnes in the first quarter, down 11.7 percent from output the year before, the Energy and Mining Ministry said in a statement on Wednesday.

 
ASX drops for a fifth straight session

2018-05-23 theage.com.au
Australian shares have closed the day lower despite a positive performance in early trade as it recorded its fifth consecutive fall.

 
ASX drops for a fifth straight session

2018-05-23 smh.com.au
Australian shares have closed the day lower despite a positive performance in early trade as it recorded its fifth consecutive fall.

 
Midas Gold Increases Board Size to Eight & Appoints an Additional Director

2018-05-22 globenewswire
VANCOUVER, British Columbia, May 22, 2018 (GLOBE NEWSWIRE) -- Midas Gold Corp. (TSX:MAX) (OTCQX:MDRPF) (“Midas Gold” or the “Company”) today announced that it has increased the size of its board of directors from seven to eight and appointed Mark Hill, Chief Investment Officer with Barrick Gold Corporation (NYSE:ABX) (TSX:ABX) (“Barrick”) to fill the additional position. The increase in board size and the appointment of a Barrick nominee to the board of directors is in accordance with the terms of the investor rights agreement entered into with Barrick in conjunction with the strategic investment by Barrick in Midas Gold that was completed on May 16, 2018.

 
Investor Confidence In Higher Copper Remains Strong

2018-05-21 seekingalpha
Copper equities have rallied significantly since last year, while the copper price is up 17% year-to-date.

 
BHP's EV Plans For Nickel West - More Than Putting Lipstick On A Pig

2018-05-20 seekingalpha
In August 2017, BHP Billiton (BHP) revealed plans to join the EV boom by investing USD 43mn in a sulfate plant at the Kwinana refinery in Western Australia, which forms part of its Nickel West division. With an annual capacity of 100,000 tonnes per year, it could be the world’s largest nickel sulfate plant. First production is expected in April 2019 and BHP said that it was also considering a stage two expansion of the nickel sulphate plant to 200,000 tonnes per year depending on industry demand.

1
Roth IRAs From A Retiree's Perspective - Great For The Young And Young At Heart

2018-05-18 seekingalpha
Roth IRAs are going to be the most fun to write about of any of the postings in this series. There are just so many benefits to Roth accounts that they are fun to think about. It isn't just about taxes, but they're good place to start.

 
Should You Invest in the iShares Global Materials ETF (MXI)?

2018-05-18 zacks
Looking for broad exposure to the Materials - Broad segment of the U.S. equity market? You should consider the iShares Global Materials ETF (MXI - Free Report) , a passively managed exchange traded fund launched on 09/12/2006.

 
Digging For Dividends Pt. 2: Southern Copper Corporation

2018-05-17 seekingalpha
Copper is a vital industrial metal whose recent runup from its 2016 lows may have more room to run.

 
What’s Making Carl Icahn Bearish on Freeport-McMoRan?

2018-05-17 marketrealist
According to recent regulatory filings, activist investor Carl Icahn cut his holdings in Freeport-McMoRan (FCX). Icahn built his position in Freeport-McMoRan in 2015, when miners including BHP Billiton (BHP), Glencore (GLNCY), and Rio Tinto (RIO) were battling a commodity price slowdown.

 
PRESS DIGEST- British Business - May 17

2018-05-17 reuters
May 17 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

 
[email protected]: ASX to open higher as investors await jobs data

2018-05-16 theage.com.au
The Australian share market is due to open higher after Wall Street notched solid gains, recouping some of the market's losses from a day earlier.

 
[email protected]: ASX to open higher as investors await jobs data

2018-05-16 smh.com.au
The Australian share market is due to open higher after Wall Street notched solid gains, recouping some of the market's losses from a day earlier.

 
Trump Pick For US State Department Energy Job Approved By Senate Panel

2018-05-16 rigzone
WASHINGTON, May 16 (Reuters) - President Donald Trump's nominee for the top U.S. State Department job dealing with matters related to energy and the global oil industry was approved by a Senate committee on Wednesday, as the United States gears up to re-impose sanctions on Iran's oil exports.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...